Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
Sacomni 50
Composition
24 mg Sacubitril and 26 mg Valsartan as sodium salt complex, along with approved excipients
Dosage Strength
24 mg & 26 mg
Medicine Type
Tablet
Pack Size
10 X 14 Tablets
Storage Instructions
Sacomni 50 Sacubitril and Valsartan Tablets should be stored in a cool, dry and dark place at a temperature below 25°C.
Caution
Keep out of reach of children. Consult your physician if you experience any adverse effects.
Product Information
Sacomni 50 by EMK Omni Pharma is a prescription-based Sacubitril and Valsartan Tablets formulation used for doctor-supervised heart failure management, cardiac function support and cardiovascular health care. Each film-coated tablet contains Sacubitril 24 mg and Valsartan 26 mg as sodium salt complex. Sacomni 50 is commonly prescribed by healthcare professionals for patients who require support in managing heart failure, cardiac workload, blood pressure control and long-term heart health. Sacomni 50 Sacubitril 24 mg and Valsartan 26 mg Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where heart failure support, vascular health, blood pressure management and cardiovascular risk management are required. This medicine should be used only as advised by a registered medical practitioner. Sacomni 50 may be prescribed by doctors for patients who require support in managing heart failure, cardiac strain, blood pressure concerns and cardiovascular health risks. It may be used as part of a physician-guided heart care plan where cardiac function support, vascular balance and long-term cardiovascular management are required. Sacomni 50 by EMK Omni Pharma is suitable for doctor-supervised treatment where heart failure management, cardiac health support and blood pressure control are needed. Patients should not self-medicate, change the dosage, stop the medicine or combine it with other heart medicines without consulting their doctor. As mentioned on the product label, Valsartan should be discontinued as soon as pregnancy is detected, and patients must consult their physician immediately in such cases.
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.